Covid-19 phase II randomized study of convalescent plasma from recovered covid-19 donors collected by plasmapheresis as treatment for subjects with early covid-19 infection
Ended Project Grant Awarded Last action
- Award ID
- W81XWH2110064
- Recipient
-
HMH Hospitals Corporation UEI LV8GL8MLU9A3
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $1,093,693
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date
- Place of performance
- Edison, NJ 08837, USA
Award details come from USAspending.gov.
About this award
The Department of the Army Medical Command awarded a $1,093,692.71 Project Grant to HMH Hospitals Corporation, doing business as Hackensack University Medical Center, to support a randomized clinical study of convalescent plasma from recovered COVID-19 donors collected through plasmapheresis as treatment for early COVID-19 infection. The study aims to evaluate the safety and efficacy of convalescent plasma as a treatment option for COVID-19 under the Military Medical Research and Development program (CFDA #12.420), which supports innovative medical research to improve health care for service members and the public through investigations into battlefield medicine solutions and other areas. The period of performance for this clinical trial grant is February 1, 2021 through April 20, 2022.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | -$406,307 | |
| Amendment | $0 | |
| Amendment | -$3,992,928 | |
| Original award | $5,492,928 |
Quick answers
Who received award W81XWH2110064?
W81XWH2110064 was awarded to HMH Hospitals Corporation by Medical Command (Department of the Army) on February 1, 2021.
How much is award W81XWH2110064 worth?
$1,093,693 has been obligated on W81XWH2110064.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award